MedPath

The effects of rutin flavonoid on type 2 diabetes mellitus

Phase 2
Conditions
Type 2 diabetes mellitus.
Type 2 diabetes mellitus
Registration Number
IRCT20170116031993N5
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
48
Inclusion Criteria

Willingness to participate in the study
People between 20 to 60 years old in both sexes,
Over at least 2 years from time of diagnosis of type 2 diabetes mellitus
Body mass index (BMI) less than 35 (BMI = 35)
Glycosylated hemoglobin (HbA1c) between 6.5 to 11%

Exclusion Criteria

Developing complications from diabetes such as renal failure
Diabetic patients taking insulin
Thyroid disease
Anemia
Pregnancy, lactation
Smokers
Use of other dietary supplements, probiotics and anti-inflammatory drugs
Use of any antioxidant supplements in the last 3 months
Use of immunosuppressive drugs
Following of special diets other than the diet specific to diabetic patients,

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic blood pressure, diastole, pulse pressure, mean arterial pressure and heart rate. Timepoint: Before and after the intervention. Method of measurement: Using digital sphygmomanometer.;Quality of Life. Timepoint: Before and after the intervention. Method of measurement: Questionnaire 36 items.;Catalase enzyme. Timepoint: Before and after the intervention. Method of measurement: ELISA kit.;Superoxide dismutase enzyme. Timepoint: Before and after the intervention. Method of measurement: ELISA kit.;Glutathione peroxidase. Timepoint: Before and after the intervention. Method of measurement: ELISA kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath